Legal & General Group PLC Capricor Therapeutics, Inc. Transaction History
Legal & General Group PLC
- $368 Billion
- Q4 2024
A detailed history of Legal & General Group PLC transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 30,783 shares of CAPR stock, worth $354,004. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,783
Previous 2,725
1029.65%
Holding current value
$354,004
Previous $41,000
939.02%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CAPR
# of Institutions
132Shares Held
15.9MCall Options Held
1.73MPut Options Held
1.71M-
Vanguard Group Inc Valley Forge, PA2.28MShares$26.2 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.25MShares$25.9 Million0.17% of portfolio
-
State Street Corp Boston, MA2.21MShares$25.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$18.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA879KShares$10.1 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $280M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...